Skip to Content

RPR 202 (Rilutek 50 mg)

Generic Name: riluzole

Pill imprint RPR 202 has been identified as Rilutek 50 mg.

Rilutek is used in the treatment of amyotrophic lateral sclerosis and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy. Rilutek 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rilutek 50 mg RPR 202
Rilutek 50 mg RPR 202
Rilutek 50 mg RPR 202
Rilutek
Generic Name:
riluzole
Imprint:
RPR 202
Strength:
50 mg
Color:
White
Size:
10.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Miscellaneous uncategorized agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Aventis Pharmaceuticals
National Drug Code (NDC):
00075-7700
Inactive Ingredients:
calcium phosphate dibasic anhydrous
microcrystalline cellulose
silicon dioxide
magnesium stearate
croscarmellose sodium
hypromelloses
polyethylene glycol 6000
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
64980-0191 Rising Pharmaceuticals, Inc.
42291-0723 AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide